Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Dude51on Jan 31, 2021 2:08am
115 Views
Post# 32430541

RE:RE:RE:RE:RE:RE:RE:Soon

RE:RE:RE:RE:RE:RE:RE:Soon
The jury is still out on the vaccine debate as to how long the vaccines of today work for.  Just read that someone got inoculated and still got Covid. It’s not 100%, it’s not a done deal. It’s far from over.
 
NO as a gas is given to babies with lung issues etc and have been doing it for years. NO has antibacterial qualities and is one reason they give to people/kids with serious lung infections. Our bodies produce NO. We have a chance to develop the liquid form and to claim all discoveries as ours going forward with license deal with Salzman.
 
Do you think Barda won't take a chance on KLY especially with its ties to the Salzman group who Barda just cancelled the remainder of a 15.9 million dollar contract with Salzman because the research was not Covid enough, “to support projects for the prevention of COVID-19.” was the new goal for Barda.
One more thing about Barda, that contract that was cancelled was under the orange turd, Biden may just have to reverse that idea with an executive order, go Joe go. It could happen.
 
KLY has 546,075,967 outstanding shares. There not buying Salzman, therefore no dilution there, RS is possible.
"Following the termination of the BARDA contract, on about Sept. 28, 2020, Kalytera determined that it was no longer in the best interests of the company to go forward with the acquisition of Salzman Group. Instead, the company will proceed to develop R-107 under the company's exclusive worldwide license for the development and commercialization of R-107 for the treatment of COVID-19."
 
And just because the OSC and BCSC shut KLY down for 7 months (main cause for length of time was due to the pandemic) nothing nefarious as the bashers would have you believe. Sorry when I say bashers I really mean shorters, who else would say shiit about a company that could help with the pandemic, selfish batterds. So during the shutdown KLY employees were still working/planning phase 1, the study of R-107 on people, they were not working on their resume’s as the basher would have you believe.
 
GLTA
<< Previous
Bullboard Posts
Next >>